Michael Chambers
Vermögen: 9 Mio $ am 31.05.2026
Vermögen: 9 Mio $ am 31.05.2026
Michael Chambers was the founder of Altravax, Inc. (2009, Director) and Aldevron LLC (1998, Chairman).
Current jobs include Independent Director at Sarepta Therapeutics, Inc. (2022), Director at Whitehead Institute for Biomedical Research (2022), Director at Calviri, Inc. (2020), Director at Lykan Biosciences LLC, and Director at Agathos Biologics LLC (2020).
Former job includes Director at NDSU Research Technology Park, Inc. Education includes an undergraduate degree from North Dakota State University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.06.2026 | 504.027 ( 0,48 % ) | 9 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 02.06.2022 |
Calviri, Inc.
Calviri, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops vaccines to eliminate cancer | Direktor/Vorstandsmitglied | 18.08.2020 |
Lykan Biosciences LLC | Direktor/Vorstandsmitglied | - |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Direktor/Vorstandsmitglied | 08.12.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
Aldevron LLC
Aldevron LLC BiotechnologyHealth Technology Manufactures and develops biological science products | Vorstandsvorsitzender | 13.07.2020 |
NDSU Research Technology Park, Inc.
NDSU Research Technology Park, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a research and technology park where university researchers and private industry develops new technologies | Direktor/Vorstandsmitglied | - |
Altravax, Inc.
Altravax, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new vaccines to fight infectious diseases | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Altravax, Inc.
Altravax, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new vaccines to fight infectious diseases | Health Technology |
Aldevron LLC
Aldevron LLC BiotechnologyHealth Technology Manufactures and develops biological science products | Health Technology |
North Dakota State University
North Dakota State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Commercial Services |
NDSU Research Technology Park, Inc.
NDSU Research Technology Park, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a research and technology park where university researchers and private industry develops new technologies | Commercial Services |
Calviri, Inc.
Calviri, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops vaccines to eliminate cancer | Health Technology |
Lykan Biosciences LLC |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen